Opaleye Management Inc. - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 52 filers reported holding EDGE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$1,334,000
-47.7%
130,000
-53.6%
0.56%
-56.1%
Q1 2017$2,550,000
-27.1%
280,0000.0%1.27%
-38.5%
Q4 2016$3,500,000
+20.1%
280,0000.0%2.06%
+35.1%
Q3 2016$2,915,000
+27.8%
280,000
+24.1%
1.53%
+0.1%
Q2 2016$2,281,000
+34.7%
225,600
+21.9%
1.52%
+44.3%
Q1 2016$1,693,000185,0001.06%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$1,923,0000.35%
Sofinnova Investments, Inc. 2,852,711$2,339,0000.21%
Ghost Tree Capital, LLC 1,000,000$820,0000.17%
REGENTATLANTIC CAPITAL LLC 69,900$57,0000.00%
A.R.T. Advisors, LLC 40,853$33,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 19,680$16,0000.00%
Raymond James Financial Services Advisors, Inc. 158,463$130,0000.00%
D. E. Shaw & Co., Inc. 759,721$623,0000.00%
ADVANTAGE INVESTMENT MANAGEMENT, LLC 900$1,0000.00%
TWO SIGMA INVESTMENTS, LP 267,589$219,0000.00%
View complete list of EDGE THERAPEUTICS INC shareholders